Summary:
Click image to enlargeA Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to
Evaluate the Efficacy and Safety of VT-1161 Oral Capsules in the
Treatment of Subjects with Recurrent Vulvovaginal Candidiasis
Qualified Participants Must:
• Be Female
•
Have at least 3 vaginal yeast infections within the last 12 months
•
At least one infection must have been confirmed by laboratory/diagnostic test
•
You must have an active infection during your first visit to the study clinic
Qualified Participants May Receive:
Payment for time and travel.